Covid-19: No negative outcome on people with uncomplicated liver transplants, no co-morbidities, new study finds

By: |
September 05, 2021 12:52 PM

The aim of the study was to understand how these people responded to the virus as they have to on ‘immunosuppressive medications’ which leave them susceptible to infections.

covid impact liver transplantsThe team studied several people who had undergone liver transplants since 2006, including those suffering from by Covid-19

Covid-19 did not have a negative impact on people with uncomplicated liver transplants and no co-morbid conditions, a new study conducted by a Delh-based private hospital has found.

The independent study, conducted by Max Super Speciality Hospital in Saket, was led Dr. Subhash Gupta, chairman of the Centre for Liver and Biliary Sciences unit.

The team studied several people who had undergone liver transplants since 2006, including those suffering from by Covid-19. The aim of the study was to understand how these people responded to the virus as they have to on ‘immunosuppressive medications’ which leave them susceptible to infections.

The hospital authorities told PTI that the study was based on over 2,100 adult transplant recipients at its Centre for Liver and Biliary Sciences and the Department of Gastroenterology and Hepatology. These patients have been under follow-up since 2006.

According to the study, recipients with uncomplicated liver transplants and no co-morbid conditions did not have a poor outcome after getting infected by Covid-19.

For recipients with complicated transplants, doctors said the severe ones recovered following treatment. They were later administered the monoclonal cocktail therapy, and their response was good.

Covid-19 is typically associated with higher mortality among people with comorbidities or have pre-existing medical conditions, including diabetes, obesity, chronic kidney disease, coronary artery disease, and non-alcoholic fatty liver disease.

Dr. Gupta said it is established that patients who undergo liver transplants have to be on long-term immunosuppressive medications that can make them vulnerable to infections. He said the study was significant as data on the impact of SARS-CoV-2 infections in liver transplants patients was conflicting, and risk factors not well defined.

Initial studies had suggested that people taking immunosuppressive medicines were at a higher risk of severe Covid-19 infection and mortality. However, subsequent studies did not corroborate this finding, Dr. Gupta said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Centre ask states to step up efforts against Serotype-II dengue cases; here how to keep your guard up
2Over 78.58 crore COVID-19 vaccine doses provided to states, UTs so far: Centre
3Coronavirus Live Updates: Zero social distancing, very few masks – Mumbai flouts Covid norms during Ganesh Visarjan